Jim Cramer Advises His Viewers On Array Biopharma, GoPro & Sprint Corp

On CNBC's Mad Money, Jim Cramer said that Array Biopharma Inc ARRY is a very speculative stock and he would own something less speculative in the current market environment.

Cramer thinks that GoPro Inc GPRO was really good when it had a tight flow, but now he just wants to move onto a different trade.

Sprint Corp S won't move much higher in the near term, he said, because the government hasn't allowed a merger with T-Mobile US Inc TMUS.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CNBCMediaJim CramerMad Money
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!